Related Experiment Video
Updated: Jun 19, 2026

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
Published on: October 5, 2020
RalA suppresses early stages of Ras-induced squamous cell carcinoma progression
A G Sowalsky1, A Alt-Holland, Y Shamis
1Sackler School of Graduate Biomedical Sciences, Tufts University School of Medicine, Boston, MA 02111, USA.
Abstract:
Ras proteins activate Raf and PI-3 kinases, as well as exchange factors for RalA and RalB GTPases. Many previous studies have reported that the Ral-signaling cascade contributes positively to Ras-mediated oncogenesis. Here, using a bioengineered tissue model of early steps in Ras-induced human squamous cell carcinoma of the skin, we found the opposite. Conversion of Ras-expressing keratinocytes from a premalignant to malignant state induced by decreasing E-cadherin function was associated with and required an approximately two to threefold decrease in RalA expression. Moreover, direct knockdown of RalA to a similar degree by shRNA expression in these cells reduced E-cadherin levels and also induced progression to a malignant phenotype. Knockdown of the Ral effector, Exo84, mimicked the effects of decreasing RalA levels in these engineered tissues. These phenomena can be explained by our finding that the stability of E-cadherin in Ras-expressing keratinocytes depends upon this RalA signaling cascade. These results imply that an important component of the early stages in squamous carcinoma progression may be a modest decrease in RalA gene expression that magnifies the effects of decreased E-cadherin expression by promoting its degradation.
Insights
A decrease in RalA expression is crucial for Ras-driven skin cancer progression. This reduction in RalA impacts E-cadherin stability, promoting malignant transformation in squamous cell carcinoma.
Area of Science:
- Oncology
- Cell Biology
- Dermatology
Background:
- Ras proteins are key regulators of cell signaling pathways implicated in cancer.
- The Ral-signaling cascade, involving RalA and RalB GTPases, has been considered a positive contributor to Ras-mediated oncogenesis.
- E-cadherin plays a critical role in maintaining cell-cell adhesion and tissue integrity.
Purpose of the Study:
- To investigate the role of the Ral-signaling cascade in the early stages of Ras-induced human squamous cell carcinoma.
- To determine the relationship between RalA expression, E-cadherin function, and malignant progression in a bioengineered skin cancer model.
Main Methods:
- Utilized a bioengineered tissue model of early Ras-induced human squamous cell carcinoma.
- Employing shRNA to achieve direct knockdown of RalA expression in keratinocytes.
- Assessed the impact of RalA knockdown on E-cadherin levels and malignant phenotype.
- Investigated the role of the Ral effector, Exo84, in these processes.
Main Results:
- Decreased E-cadherin function in Ras-expressing keratinocytes led to a two to threefold reduction in RalA expression during malignant conversion.
- Direct knockdown of RalA significantly reduced E-cadherin levels and induced a malignant phenotype.
- Knockdown of the Ral effector, Exo84, replicated the effects of RalA reduction.
- E-cadherin stability in Ras-expressing keratinocytes was found to be dependent on the RalA signaling cascade.
Conclusions:
- Contrary to previous assumptions, a decrease in RalA expression is essential for the progression of Ras-induced squamous cell carcinoma.
- Reduced RalA levels promote E-cadherin degradation, thereby facilitating malignant transformation.
- Modest downregulation of RalA may represent a critical early event in squamous carcinoma development.
Related Concept Videos
The Ras Gene
Ras is a superfamily...
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...